Clinical and Biological Perspectives on Autosomal Aneuploidy

Fundamentals of Autosomal Aneuploidy

• Autosomal Monosomy: Monosomies involving autosomes are not viable. An individual must possess at least two copies of every single autosome to survive.

• Autosomal Trisomy: Only three specific autosomal trisomies are considered viable in humans: Trisomy $13$, Trisomy $18$, and Trisomy $21$.

• Non-Viable Trisomies: Trisomies of other chromosomes (e.g., Trisomy $1$, $2$, $3$, etc.) are not viable.

• Clinical Severity: While Trisomies $13$, $18$, and $21$ are classified as viable, Patau and Edwards syndromes (Trisomies $13$ and $18$) are extremely severe conditions. There is a spectrum of severity regarding phenotypes, but these two represent the severe end of that spectrum.

Nomenclature and Mnemonics for Viable Trisomies

• Trisomy $13$ (Patau Syndrome): Associated with the age of $13$ (becoming a teenager/puberty). The mnemonic "P" for Puberty and Patau can be used.

• Trisomy $18$ (Edwards Syndrome): Associated with the age of $18$ (legal age to vote/drink). The mnemonic "E" for eighteen and Edwards syndrome can be used.

• Trisomy $21$ (Down Syndrome): Associated with the age of $21$ (traditionally receiving the "key to the house").

Trisomy $13$: Patau Syndrome

• Karyotype Annotation: A karyotype for Patau syndrome is written by noting the total chromosome count followed by the sex chromosomes and the specific extra chromosome.

  • Female: $47, XX, +13$

  • Male: $47, XY, +13$

  • The "$+13$" indicates the presence of an extra chromosome $13$.

• Incidence: Occurs in approximately $1$ in $10,000$ live births.

• Clinical Presentation:

  • Severe phenotype featuring significant developmental delay and intellectual disability.

  • Underdeveloped brain.

  • Cleft lip and/or palate.

  • Polydactyly: The presence of extra fingers or toes.

• Prognosis: Over half of affected infants will die within the first month after birth. Very few individuals survive beyond the first year of life.

Trisomy $18$: Edwards Syndrome

• Karyotype Annotation: Characterized by an extra chromosome $18$.

  • Female: $47, XX, +18$

  • Male: $47, XY, +18$

• Incidence: Occurs in approximately $1$ in $5,000$ live births.

• Clinical Presentation:

  • Developmental delay and intellectual disability.

  • Abnormalities involving the hands and feet.

  • Kidney and heart abnormalities.

  • Polydactyly (extra fingers or toes).

• Prognosis: Approximately half of affected individuals die within the first week of life. Only about $10\%$ survive beyond the first year due to the severity of the associated abnormalities.

Trisomy $21$: Down Syndrome

• Incidence: Occurs in approximately $1$ in $1,000$ live births.

• Developmental Features:

  • Presents with some level of developmental and intellectual delay.

  • Early Intervention: Modern therapeutic interventions and early childhood support can significantly ameliorate developmental effects, helping individuals live independently and maintain employment.

• Physical Phenotype:

  • Characteristic facial appearance.

  • Low muscle tone.

  • Characteristic hand crease: A specific single crease across the palm.

  • Sandal Gap: An enhanced, wide gap between the big toe and the second toe.

• Primary Medical Concerns:

  • Heart Defects: This is the most critical medical concern. Infants must undergo heart scans immediately upon diagnosis and throughout the first year of life to ensure proper valve closure and blood flow. Early surgical intervention to correct defects generally leads to healthy outcomes.

  • Childhood Leukemia: There is a higher incidence of leukemia in children with Down syndrome. Consequently, their blood is monitored closely. Fortunately, this leukemia tends to respond very favorably to treatment.

• Survival and Longevity: If heart defects are repaired and leukemia is successfully treated, individuals with Down syndrome can have a lifespan comparable to that of individuals without the syndrome.

• Cancer Protection: Interestingly, while they have a higher risk for leukemia, individuals with Down syndrome have a much lower incidence of solid tumors, such as breast, liver, or pancreatic cancer. An extra copy of chromosome $21$ appears to provide a protective effect against these types of cancers.

Biological Rationale for the Rarity of Viable Aneuploidies

• Gene Density on Autosomes: Most autosomes contain a large number of genes. Successful development during embryogenesis and brain formation requires tightly regulated gene expression—meaning the right level of expression at the correct time and in the specific cells.

• Gene Balance and Protein Complexes: Proper development sequence (embryonic patterning) depends on specific amounts of proteins produced by genes on different chromosomes to form functional complexes.

• The Sheltering Complex Example: This complex protects telomeres from degradation and consists of multiple proteins encoded by genes on various chromosomes including chromosomes $1$, $16$, $14$, $8$, $11$, and $7$.

  • Imbalance Scenario: If an individual has Trisomy $8$, they produce an excess of the protein $TRF1$.

  • This excess can throw out the stoichiometric balance of the complex, potentially rendering it non-functional.

  • While this specific example involves telomeres, similar imbalances in complexes responsible for body patterning, brain development, and neural networks are often fatal.

• Viability of Chromosome $21$: Unlike chromosomes $13$ and $18$, which result in severe or borderline-viable conditions, chromosome $21$ is survivable likely due to the specific genes it contains. Having three sets of the genetic information on chromosome $21$ is less disruptive to the overall biological system than other autosomal additions.